Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

By Grillo Mary   Bott Matthew   Khandke Neha   McGinnis John   Miranda Miriam   Meyyappan Muthupalaniappan   Rosfjord Edward   Rabindran Sridhar  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 185-194

Springer Publishing Company

Access to resources Recommend Favorite

Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma

By Kim Y.T.   Cho N.H.   Park S.W.   Kim J.W.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 38-45

Elsevier

Access to resources Recommend Favorite

The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo

By            

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 804-812

Spandidos Publications

Access to resources Recommend Favorite

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias

By Gojo Ivana   Sadowska Mariola   Walker Alison   Feldman Eric   Iyer Swaminathan   Baer Maria   Sausville Edward   Lapidus Rena   Zhang Da   Zhu Yali   Jou Ying-Ming   Poon Jennifer   Small Karen   Bannerji Rajat  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 897-908

Springer Publishing Company

Access to resources Recommend Favorite

Expression and Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27 Kip1 in Epithelial Ovarian Cancer

By Hurteau J.A.   Allison B.M.   Brutkiewicz S.A.   Goebl M.G.   Heilman D.K.   Bigsby R.M.   Harrington M.A.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 292-298

Elsevier

Access to resources Recommend Favorite